(Q86953859)

English

The problem with repurposing: Is there really an alternative to Big Pharma for developing new drugs for multiple sclerosis?

scientific article published on 21 November 2014

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25787047

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25787047%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 March 2020

title

The problem with repurposing: Is there really an alternative to Big Pharma for developing new drugs for multiple sclerosis? (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25787047

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25787047%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 March 2020

author name string

Gavin Giovannoni

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25787047

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25787047%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 March 2020

David Baker

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25787047

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25787047%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 March 2020

Klaus Schmierer

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25787047

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25787047%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 March 2020

publication date

21 November 2014

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25787047

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25787047%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 March 2020

published in

Multiple Sclerosis and Related Disorders

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25787047

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25787047%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 March 2020

volume

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25787047

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25787047%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 March 2020

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25787047

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25787047%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 March 2020

page(s)

3-5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25787047

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25787047%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 March 2020

Identifiers

DOI

10.1016/J.MSARD.2014.11.005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25787047

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25787047%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 March 2020

PubMed publication ID

25787047

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25787047

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25787047%20AND%20SRC:MED&resulttype=core&format=json

(Q86953859)

The problem with repurposing: Is there really an alternative to Big Pharma for developing new drugs for multiple sclerosis?

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)